Polymorphisms in metabolic genes CYP1A1 and GSTM1 and changes in maternal smoking during pregnancy

Nicotine and Tobacco Research

Volumn 11, Issue 3, 2009, Pages 225-233

  Chen, Xinguang ^a   Woodcroft, Kimberley J ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE M1;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MATERNAL BEHAVIOR; MATERNAL SMOKING; NUCLEIC ACID BASE SUBSTITUTION; ONSET AGE; POLYMORPHIC LOCUS; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SMOKING CESSATION;

ADULT; CYTOCHROME P-450 CYP1A1; FEMALE; GENE FREQUENCY; GLUTATHIONE TRANSFERASE; HUMANS; INTERVIEWS AS TOPIC; MICHIGAN; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY COMPLICATIONS; SMOKING; SMOKING CESSATION;

EID: 64949131314     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntn027     Document Type: Article

References (61)

1. Abbas, M. M., Berka, N., BoBo, L. D., & Dunston, G. M. (2004). DNA yield from buccal swabs and its utilization in HLA typing using Luminex SSO bead technology. Human Immunology, 65, S81-S81.
2. Arand, M., Muhlbauer, R., Hengstler, J., Jager, E., Fuchs, J., Winkler, L., et al. (1996). A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Analytical Biochemistry, 236, 184-186.
3. Bartsch, H., Nair, U., Risch, A., Rojas, M., Wikman, H., & Alexandrov, K. (2000). Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiology, Biomarkers, and Prevention, 9, 3-28.
4. Basham, V. M., Pharoah, P. D., Healey, C. S., Luben, R. N., Day, N. E., Easton, D. F., et al. (2001). Polymorphisms in CYP1A1 and smoking: No association with breast cancer risk. Carcinogenesis, 22, 1797-1800.
5. Bell, J. F., Zimmerman, F. J., Mayer, J. D., Almgren, G. R., & Huebner, C. E. (2007). Associations between residential segregation and smoking during pregnancy among urban African-American women. Journal of Urban Health, 84, 372-388.
6. Benowitz, N. L., & Jacob, P., III (1994). Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clinical Pharmacology and Therapeutics, 56, 483-493.
7. Benowitz, N. L., & Jacob, P., III (2000). Effects of cigarette smoking and carbon monoxide on nicotine and cotinine metabolism. Clinical Pharmacology and Therapeutics, 67, 653-659.
8. Benowitz, N. L., Perez-Stable, E. J., Herrera, B., & Jacob, P., III (2002). Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. Journal of the National Cancer Institute, 94, 108-115.
9. Britton, G. R., Brinthaupt, J., Stehle, J. M., & James, G. D. (2004). Comparison of self-reported smoking and urinary cotinine levels in a rural pregnant population. Journal of Obstetric, Gynecologic and Neonatal Nursing, 33, 306-311.
10. Burim, R. V., Canalle, R., Martinelli Ade, L., & Takahashi, C. S. (2004). Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYP1A1 and susceptibility to cirrhosis or pancreatitis in alcoholics. Mutagenesis, 19, 291-298.
11. Chen, X., Stanton, B., Shankaran, S., & Li, X. (2006). Age of smoking onset as a predictor of smoking cessation during pregnancy. American Journal of Health Behavior, 30, 247-258.
12. Cornelius, M. D., Leech, S. L., & Goldschmidt, L. (2004). Characteristics of persistent smoking among pregnant teenagers followed to young adulthood. Nicotine & Tobacco Research, 6, 159-169.
13. Ebrahim, S. H., Floyd, R. L., Merritt, R. K., II, Decoufle, P., & Holtzman, D. (2000). Trends in pregnancy-related smoking rates in the United States, 1987-1996. The Journal of the American Medical Association, 283, 361-366.
14. Fichtner, R. R., Sullivan, K. M., Zyrkowski, C. L., & Trowbridge, F. L. (1990). Racial/ethnic differences in smoking, other risk factors, and low birth weight among low-income pregnant women, 1978-1988. MMWR CDC Surveillance Summary, 39, 13-21.
15. Firozi, P. F., Bondy, M. L., Sahin, A. A., Chang, P., Lukmanji, F., Singletary, E. S., et al. (2002). Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer. Carcinogenesis, 23, 301-306.
16. Florek, E., Piekoszewski, W., Rybakowski, L., & Moczko, J. (2004). Using questionnaire and cotinine concentration in urine for studying the smoking habits and ETS exposure of pregnant women. Przegl Lek, 61, 993-996.
17. Freedman, D., Thornton, A., Camburn, D., Alwin, D., & Young-Demarco, L. (1988). The life history calendar: A technique for collecting retrospective data. Sociological Methodology, 18, 37-68.
18. Fukami, T., Nakajima, M., Higashi, E., Yamanaka, H., McLeod, H. L., & Yokoi, T. (2005). A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity. Biochemical Pharmacology, 70, 801-808.
19. Gambier, N., Marteau, J. B., Batt, A. M., Marie, B., Thompson, A., Siest, G, et al. (2006). Interaction between CYP1A1 T3801C and AHR G1661A polymorphisms according to smoking status on blood pressure in the Stanislas cohort. Journal of Hypertension, 24, 2199-2205.
20. Georgiadis, P., Topinka, J., Vlachodimitropoulos, D., Stoikidou, M., Gioka, M., Stephanou, G., et al. (2005). Interactions between CYP1A1 polymorphisms and exposure to environmental tobacco smoke in the modulation of lymphocyte bulky DNA adducts and chromosomal aberrations. Carcinogenesis, 26, 93-101.
21. Gilliland, F. D., Li, Y. F., Dubeau, L., Berhane, K., Avol, E., McConnell, R., et al. (2002). Effects of glutathione S-transferase M1, maternal smoking during pregnancy, and environmental tobacco smoke on asthma and wheezing in children. American Journal of Respiratory and Critical Care Medicine, 166, 457-463.
22. Heath, A. C., Knopik, V. S., Madden, P. A., Neuman, R. J., Lynskey, M. J., Slutske, W. S., et al. (2003). Accuracy of mothers' retrospective reports of smoking during pregnancy: Comparison with twin sister informant ratings. Twin Research, 6, 297-301.
23. Hozyasz, K. K., Mostowska, A., Surowiec, Z., & Jagodzinski, P. P. (2005). [Genetic polymorphisms of GSTM1 and GSTT1 in mothers of children with isolated cleft lip with or without cleft palate]. Przegl Lek, 62 1019-1022.
24. Hung, R. J., Boffetta, P., Brockmoller, J., Butkiewicz, D., Cascorbi, I., Clapper, M. L., et al. (2003). CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: A pooled analysis. Carcinogenesis, 24, 875-882.
25. Iba, M. M., Scholl, H., Fung, J., Thomas, P. E., & Alam, J. (1998). Induction of pulmonary CYP1A1 by nicotine. Xenobiotica, 28, 827-843.
26. Infante-Rivard, C., Weinberg, C. R., & Guiguet, M. (2006). Xenobiotic-metabolizing genes and small-for-gestational-age births: Interaction with maternal smoking. Epidemiology, 17, 38-46.
27. Ishibe, N., Wiencke, J. K., Zuo, Z. F., McMillan, A., Spitz, M., & Kelsey, K. T. (1997). Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans. Cancer Epidemiology, Biomarkers, and Prevention, 6, 1075-1080.
28. Kesmodel, U., & Olsen, S. F. (1999). Smoking habits among pregnant Danish women: Reliability of information recorded after delivery. Journal of Epidemiology and Community Health, 53, 239-242.
29. Kim, J. W., Lee, C. G., Park, Y. G., Kim, K. S., Kim, I. K., Sohn, Y. W., et al. (2000). Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: Relation to the incidence rate of cervical carcinoma. Cancer, 88, 2082-2091.
30. King, I. B., Satia-Abouta, J., Thornquist, M. D., Bigler, J., Patterson, R. E., Kristal, A. R., et al. (2002). Buccal cell DNA yield, quality, and collection costs: Comparison of methods for large-scale studies. Cancer Epidemiology, Biomarkers, and Prevention, 11(Pt. 1), 1130-1133.
31. Kiyohara, C., Hirohata, T., & Inutsuka, S. (1996). The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Japanese Journal of Cancer Research, 87, 18-24.
32. Kubota, T., Nakajima-Taniguchi, C., Fukuda, T., Funamoto, M., Maeda, M., Tange, E., et al. (2006). CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation. Pharmacogenomics Journal, 6, 115-119.
33. Lammer, E. J., Shaw, G. M., Iovannisci, D. M., & Finnell, R. H. (2005). Maternal smoking, genetic variation of glutathione S-transferases, and risk for orofacial clefts. Epidemiology, 16, 698-701.
34. Landi, M. T., Bertazzi, P. A., Shields, P. G., Clark, G., Luder, G. W., Garte, S. J., et al. (1994). Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics, 4, 242-246.
35. Li, Y., Millikan, R. C., Bell, D. A. Cui, L., Tse, C. K., Newman, B., et al. (2005). Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast-cancer risk among African American women and White women in North Carolina: A population-based case-control study. Breast Cancer Research, 7, R12-R18.
36. Malaiyandi, V., Sellers, E. M., & Tyndale, R. F. (2005). Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. Clinical Pharmacology and Therapeutics, 77, 145-158.
37. Mathews, T. J. (1998). Smoking during pregnancy, 1990-96. National Vital Statistics Report, 47, 1-12.
38. Mathews, T. J. (2001). Smoking during pregnancy in the 1990s. National Vital Statistics Report, 49, 1-14.
39. Mohsin, M., & Bauman, A. E. (2005). Socio-demographic factors associated with smoking and smoking cessation among 426,344 pregnant women in New South Wales, Australia. BMC Public Health, 5, 138.
40. National Center for Health Statistics. (1998). Health, United States, 1998 with socioeconomic status and health chartbook. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics.
41. Okada, T., Kawashima, K., Fukushi, S., Minakuchi, T., & Nishimura, S. (1994). Association between a cytochrome P450 CYPIA1 genotype and incidence of lung cancer. Pharmacogenetics, 4, 333-340.
42. Pickett, K. E., Rathouz, P. J., Kasza, K., Wakschlag, L. S., & Wright, R. (2005). Self-reported smoking, cotinine levels, and patterns of smoking in pregnancy. Paediatric and Perinatal Epidemiology, 19, 368-376.
43. Price, R. J., Renwick, A. B., Walters, D. G., Young, P. J., & Lake, B. G. (2004). Metabolism of nicotine and induction of CYP1A forms in precision-cut rat liver and lung slices. Toxicology In Vitro, 18, 179-185.
44. Rand, C. M., Weese-Mayer, D. E., Maher, B. S., Zhou, L., Marazita, M. L., & Berry-Kravis, E. M. (2006). Nicotine metabolizing genes GSTT1 and CYP1A1 in sudden infant death syndrome. American Journal of Medical Genetics A, 140, 1447-1452.
45. Sasaki, S., Kondo, T., Sata, F., Saijo, Y., Katoh, S., Nakajima, S., et al. (2006). Maternal smoking during pregnancy and genetic polymorphisms in the Ah receptor, CYP1A1 and GSTM1 affect infant birth size in Japanese subjects. Molecular Human Reproduction, 12, 77-83.
46. Sato, M., Sato, T., Izumo, T., & Amagasa, T. (1999). Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis, 20, 1927-1931.
47. Schoedel, K. A., Hoffmann, E. B., Rao, Y., Sellers, E. M., & Tyndale, R. F. (2004). Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics, 14, 615-626.
48. Sergent, J. B., Sheahan, S. L., & Latimer, M. (1994). Demographic predictors of smoking at initiation of antenatal care. Journal of American Academic Nurse Practitioners, 6, 573-579.
49. Sillanpaa, P., Heikinheimo, L., Kataja, V., Eskelinen, M., Kosma, V. M., Uusitupa, M., et al. (2007). CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population. Breast Cancer Research and Treatment, 104, 287-297.
50. Smits, K. M., Benhamou, S., Garte, S., Weijenberg, M. P., Alamanos, Y., Ambrosone, C., et al. (2004). Association of metabolic gene polymorphisms with tobacco consumption in healthy controls. International Journal of Cancer, 110, 266-270.
51. Strange, R. C., & Fryer, A. A. (1999). The glutathione S-transferases: Influence of polymorphism on cancer susceptibility. IARC Scientific Publications, 148, 231-249.
52. Strinic, T., Bukovic, D., Sumilin, L., Radic, A., Hauptman, D., & Mobucar, A. (2005). Socio-demographic characteristics and lifestyle habits of pregnant women smokers. Collegium Antropologicum, 29, 611-614.
53. U.S. Department of Health and Human Services. (2001). Women and smoking: A report of the surgeon general: Executive summary. Washington, DC: U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General.
54. von Schmiedeberg, S., Fritsche, E., Ronnau, A. C., Specker, C., Golka, K., Richter-Hintz, D., et al. (1999). Polymorphisms of the xenobiotic-metabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus erythematosus. Advances in Experimental Medicine and Biology, 455, 147-152.
55. Wang, X., Zuckerman, B., Pearson, C., Kaufman, G., Chen, C., Wang, G., et al. (2002). Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. The Journal of the American Medical Association, 287, 195-202.
56. Wang, X. L., Greco, M., Sim, A. S., Duarte, N., Wang, J., & Wilcken, D. E. (2002). Effect of CYP1A1 MspI polymorphism on cigarette smoking related coronary artery disease and diabetes. Atherosclerosis, 162 391-397.
57. Whyatt, R. M., Perera, F. P., Jedrychowski, W., Santella, R. M., Garte, S., & Bell, D. A. (2000). Association between polycyclic aromatic hydrocarbon-DNA adduct levels in maternal and newborn white blood cells and glutathione S-transferase P1 and CYP1A1 polymorphisms. Cancer Epidemiology, Biomarkers, and Prevention, 9, 207-212.
58. Wiemann, C. M. Berenson, A. B., & Landwehr, B. M. (1995). Racial and ethnic correlates of tobacco, alcohol and illicit drug use in a pregnant population. Journal of Reproductive Medicine, 40, 571-578.
59. Williamson, D. F., Serdula, M. K., Kendrick, J. S., & Binkin, N. J. (1989). Comparing the prevalence of smoking in pregnant and nonpregnant women, 1985 to 1986. The Journal of the American Medical Association, 261, 70-74.
60. Wrensch, M. R., Miike, R., Sison, J. D., Kelsey, K. T., Liu, M., McMillan, A., et al. (2005). CYP1A1 variants and smoking-related lung cancer in San Francisco Bay area Latinos and African Americans. International Journal of Cancer, 113, 141-147.
61. Xu, X., Kelsey, K. T., Wiencke, J. K., Wain, J. C., & Christiani, D. C. (1996). Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility. Cancer Epidemiology, Biomarkers, and Prevention, 5 687-692.